Please use this identifier to cite or link to this item: http://hdl.handle.net/10553/25487
DC FieldValueLanguage
dc.contributor.authorNieto, Conchaen_US
dc.contributor.authorBragado, Rafaelen_US
dc.contributor.authorMunicio, Cristinaen_US
dc.contributor.authorSierra-Filarde, Elenaen_US
dc.contributor.authorAlonso, Bárbaraen_US
dc.contributor.authorEscribese, María M.en_US
dc.contributor.authorDomínguez-Andrés, Jorgeen_US
dc.contributor.authorArdavín, Carlosen_US
dc.contributor.authorCastrillo Viguera, Antonio Jesúsen_US
dc.contributor.authorVegal, Miguel A.en_US
dc.contributor.authorPuig-Kröger, A.en_US
dc.contributor.authorCorbí, Angel L.en_US
dc.date.accessioned2018-02-09T03:31:44Z-
dc.date.accessioned2018-06-08T09:00:43Z-
dc.date.available2018-02-09T03:31:44Z-
dc.date.available2018-06-08T09:00:43Z-
dc.date.issued2018en_US
dc.identifier.issn1664-3224en_US
dc.identifier.otherWoS-
dc.identifier.urihttp://hdl.handle.net/10553/25487-
dc.description.abstractGM-CSF promotes the functional maturation of lung alveolar macrophages (A-MØ), whose differentiation is dependent on the peroxisome proliferator-activated receptor gamma (PPARγ) transcription factor. In fact, blockade of GM-CSF-initiated signaling or deletion of the PPARγ-encoding gene PPARG leads to functionally defective A-MØ and the onset of pulmonary alveolar proteinosis. In vitro, macrophages generated in the presence of GM-CSF display potent proinflammatory, immunogenic and tumor growth-limiting activities. Since GM-CSF upregulates PPARγ expression, we hypothesized that PPARγ might contribute to the gene signature and functional profile of human GM-CSF-conditioned macrophages. To verify this hypothesis, PPARγ expression and activity was assessed in human monocyte-derived macrophages generated in the presence of GM-CSF [proinflammatory GM-CSF-conditioned human monocyte-derived macrophages (GM-MØ)] or M-CSF (anti-inflammatory M-MØ), as well as in ex vivo isolated human A-MØ. GM-MØ showed higher PPARγ expression than M-MØ, and the expression of PPARγ in GM-MØ was found to largely depend on activin A. Ligand-induced activation of PPARγ also resulted in distinct transcriptional and functional outcomes in GM-MØ and M-MØ. Moreover, and in the absence of exogenous activating ligands, PPARγ knockdown significantly altered the GM-MØ transcriptome, causing a global upregulation of proinflammatory genes and significantly modulating the expression of genes involved in cell proliferation and migration. Similar effects were observed in ex vivo isolated human A-MØ, where PPARγ silencing led to enhanced expression of genes coding for growth factors and chemokines and downregulation of cell surface pathogen receptors. Therefore, PPARγ shapes the transcriptome of GM-CSF-dependent human macrophages (in vitro derived GM-MØ and ex vivo isolated A-MØ) in the absence of exogenous activating ligands, and its expression is primarily regulated by activin A. These results suggest that activin A, through enhancement of PPARγ expression, help macrophages to switch from a proinflammatory to an anti-inflammatory polarization state, thus contributing to limit tissue damage and restore homeostasis.en_US
dc.formatapplication/pdf-
dc.languageengen_US
dc.relation.ispartofFrontiers in Immunologyen_US
dc.rightsby-nc-nd-
dc.sourceFrontiers in Immunology [ISSN 1664-3224], v. 9, (31)en_US
dc.subject32 Ciencias médicasen_US
dc.subject.otherTranscription factoren_US
dc.subject.otherMacrophageen_US
dc.subject.otherPeroxisome proliferator-activated receptoren_US
dc.subject.otherInflammationen_US
dc.subject.otherInnate immunityen_US
dc.titleThe activin A-peroxisome proliferator-activated receptor gamma axis contributes to the transcriptome of GM-CSF-conditioned human macrophagesen_US
dc.typeinfo:eu-repo/semantics/Articleen_US
dc.typeArticleen_US
dc.identifier.doi10.3389/fimmu.2018.00031en_US
dc.identifier.scopus85041114864-
dc.identifier.isi000423553700001-
dc.contributor.authorscopusid55398451600-
dc.contributor.authorscopusid6701784236-
dc.contributor.authorscopusid26644374100-
dc.contributor.authorscopusid13410346800-
dc.contributor.authorscopusid37062870000-
dc.contributor.authorscopusid9736253800-
dc.contributor.authorscopusid56966812900-
dc.contributor.authorscopusid7004110431-
dc.contributor.authorscopusid55445301000-
dc.contributor.authorscopusid7102943426-
dc.contributor.authorscopusid6602385876-
dc.contributor.authorscopusid7005390980-
dc.identifier.crisid-;-;-;-;-;-;-;-;-;-;-;--
dc.identifier.issue31-
dc.relation.volume9en_US
dc.investigacionCiencias de la Saluden_US
dc.rights.accessrightsinfo:eu-repo/semantics/openAccess-
dc.type2Artículoen_US
dc.contributor.daisngid28134248-
dc.contributor.daisngid17555673-
dc.contributor.daisngid2574048-
dc.contributor.daisngid16979844-
dc.contributor.daisngid1912868-
dc.contributor.daisngid14572424-
dc.contributor.daisngid7055585-
dc.contributor.daisngid495731-
dc.contributor.daisngid225640-
dc.contributor.daisngid914888-
dc.contributor.daisngid800621-
dc.contributor.daisngid201243-
dc.description.numberofpages15en_US
dc.utils.revisionen_US
dc.contributor.wosstandardWOS:Nieto, C-
dc.contributor.wosstandardWOS:Bragado, R-
dc.contributor.wosstandardWOS:Municio, C-
dc.contributor.wosstandardWOS:Sierra-Filardi, E-
dc.contributor.wosstandardWOS:Alonso, B-
dc.contributor.wosstandardWOS:Escribese, MM-
dc.contributor.wosstandardWOS:Dominguez-Andres, J-
dc.contributor.wosstandardWOS:Ardavin, C-
dc.contributor.wosstandardWOS:Castrillo, A-
dc.contributor.wosstandardWOS:Vega, MA-
dc.contributor.wosstandardWOS:Puig-Kroger, A-
dc.contributor.wosstandardWOS:Corbi, AL-
dc.date.coverdateEnero 2018en_US
dc.identifier.supplement-;-;-;-;-;-;-;-;-;-;-;--
dc.identifier.supplement-;-;-;-;-;-;-;-;-;-;-;--
dc.identifier.supplement-;-;-;-;-;-;-;-;-;-;-;--
dc.identifier.supplement-;-;-;-;-;-;-;-;-;-;-;--
dc.identifier.ulpgcen_US
dc.description.sjr2,021
dc.description.jcr4,716
dc.description.sjrqQ1
dc.description.jcrqQ2
dc.description.scieSCIE
item.grantfulltextopen-
item.fulltextCon texto completo-
crisitem.author.deptGIR IUIBS: Farmacología Molecular y Traslacional-
crisitem.author.deptIU de Investigaciones Biomédicas y Sanitarias-
crisitem.author.orcid0000-0002-2057-2159-
crisitem.author.parentorgIU de Investigaciones Biomédicas y Sanitarias-
crisitem.author.fullNameCastrillo Viguera, Antonio Jesús-
Appears in Collections:Artículos
Thumbnail
Adobe PDF (2,74 MB)
Show simple item record

SCOPUSTM   
Citations

14
checked on Nov 17, 2024

WEB OF SCIENCETM
Citations

13
checked on Nov 17, 2024

Page view(s)

91
checked on Jan 27, 2024

Download(s)

160
checked on Jan 27, 2024

Google ScholarTM

Check

Altmetric


Share



Export metadata



Items in accedaCRIS are protected by copyright, with all rights reserved, unless otherwise indicated.